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The embryonic mammalian kidney
maintains nephron progenitor cells
(NPCs) within a specific niche. Niche
signals have been recapitulated in
culture, allowing many million-fold
expansion of NPCs. NPC propagation
facilitates investigation of mechanisms
governing their proliferation and
differentiation and provides sufficient cell
numbers to generate kidney tissue in
vitro.
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FGF, BMP, and WNT balance embryonic nephron
progenitor cell (NPC) renewal and differentiation.
By modulating these pathways, we have created an
in vitro niche in which NPCs from embryonic kidneys
or derived from human embryonic stem cells can
be propagated. NPC cultures expanded up to one
billion-fold in this environment can be induced to
form tubules expressing nephron differentiation
markers. Single-cell culture reveals phenotypic vari-
ability within the early CITED1-expressing NPC
compartment, indicating that it is a mixture of cells
with varying progenitor potential. Furthermore, we
find that the developmental age of NPCs does not
correlate with propagation capacity, indicating that
cessation of nephrogenesis is related to factors
other than an intrinsic clock. This in vitro nephron
progenitor niche will have important applications
for expansion of cells for engraftment and will facili-
tate investigation of mechanisms that determine
the balance between renewal and differentiation in
these cells.
INTRODUCTION
The nephron is the filtering unit of the kidney and is essential for
regulating blood urea concentration and limiting water and elec-
trolyte loss. New nephron formation is limited to the fetal period
in humans and continues to postnatal day 4 (P4) in rodents. The
mature mouse kidney lacks an identifiable population of multi-
potent nephron stem cells and is not thought to replace entire
nephrons after they are lost, although replacement of damaged
cells within tubules does occur (Humphreys et al., 2008; Rinke-
vich et al., 2014). Thus, long-term organ function relies on
nephron over-capacity, which is determined during the fetal/
postnatal period (Little and Bertram, 2009). Urea excretion can
be augmented by dialysis, but transplantation is eventually
required for patients with severe organ impairment. End-stage
renal disease affects approximately 500,000 individuals in the
United States and organ availability does not match demand
(Abdel-Kader et al., 2009). Technology for ex vivo nephrogene-
sis would enable therapeutic replacement of damaged kidney
tissue, and rapid advances in reprogramming somatic cells to
the pluripotent state and differentiating these through the inter-
mediate mesoderm lineage to nephron progenitor cells (NPCs)
have brought the prospect of generating patient-specific humanDevekidney tissue within reach (Lam et al., 2014; Mae et al., 2013; Ta-
guchi et al., 2014; Takahashi and Yamanaka, 2006; Takasato
et al., 2014). Although these proof-of-principle experiments
have elegantly shown differentiation of NPCs, procedures to
expand these progenitors will be necessary for practical appli-
cations such as engraftment (Lam et al., 2014; Takasato et al.,
2014).
The mammalian kidney develops by radial addition of new
nephrons that form at the outermost cortex within a progenitor
cell niche known as the nephrogenic zone. As the collecting
duct branches, progenitor cell aggregates at the collecting
duct tips, known as cap mesenchymes, are induced to differen-
tiate into renal vesicles, polarized derivatives that are the earliest
precursors of the epithelial components of the nephron (Mori
et al., 2003). The continuous epithelial induction of NPCs causes
their depletion, necessitating a mechanism to balance progeni-
tor cell renewal with epithelial differentiation, enabling multiple
rounds of nephrogenesis. Focus on this question has led to the
discovery of distinct cell phenotypes, or compartments, that
comprise the cap mesenchyme and the specific signaling path-
ways on which these cells depend (Figure 1A) (Brown et al.,
2013; Kobayashi et al., 2008; Mugford et al., 2009; Park et al.,
2012).
The least differentiated NPC compartment is marked by
the transcriptional co-activator CITED1 and the transcription
factor SIX2 (known as the CITED1+ compartment) (Boyle
et al., 2008; Self et al., 2006). SIX2 expression is necessary
to prevent NPCs from differentiating prematurely, but no func-
tional role has been described for CITED1 and in our studies, it
is simply used as a marker for the least differentiated compart-
ment within the cap mesenchyme (Boyle et al., 2007; Self
et al., 2006). Previous studies by our group and others have
identified essential functions of the BMP, FGF, and WNT
signaling pathways in regulating the balance between renewal
and differentiation in these cells (Barak et al., 2012; Blank
et al., 2009; Brown et al., 2011a, 2013; Carroll et al., 2005;
Karner et al., 2011). We asked if our understanding of the
signaling environment for NPCs is sufficient to allow its recon-
struction by manipulation of reported signaling pathways
ex vivo. CITED1+/SIX2+ cells were used in a screening strat-
egy to combinatorially test the potential of known nephrogenic
zone signaling pathways to promote NPC renewal. We show
that CITED1+/SIX2+ cells can be propagated in an undifferen-
tiated state, yet retain the potential for epithelial differentiation.
Furthermore, these conditions can be extrapolated to human
embryonic stem cell (hESC)-derived NPCs. Overall, we have
used a predictive approach to functionally recapitulate condi-
tions in the nephrogenic zone to expand undifferentiated yet
functionally competent NPCs that can be used for nephron
regeneration experiments.lopmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inc. 229
Figure 1. SMAD Inhibition with LDN-193189
Retains NPCs in the CITED1 Compartment
In Vivo
(A) Schematic of cap mesenchyme compartments
and key signaling pathways required for their
maintenance and differentiation.
(B) Cited1creERT2-EGFP kidneys harvested at
postnatal stages. GFP expression in cap mesen-
chymes is shown (c).
(C) Immunostaining of pSMAD1/5 (black arrows)
in kidney sections isolated from E17.5 to P1.
Cap mesenchymes are outlined with dotted black
lines.
(D) pSMAD1/5 immunoblot of NZCs after
intraperitoneal injection of P0 pups with
either vehicle or 3 mg/kg of LDN twice daily
until P2. Percent remaining after LDN treatment
quantified by densitometry and normalized to
b-tubulin in graph. NZCs were isolated from
four kidney pairs per treatment group and
pooled.
(E) Fluorescent imaging of kidneys from Cited1 or
Six2 EGFP mice in vehicle and LDN-treated ani-
mals. Representative image from four kidney pairs
per group are shown.
(F) Cap mesenchyme marker analysis of isolated
NZCs by qPCR. Data represent the mean ± SD of
qPCR technical replicates from five (DMSO) and
six (LDN) pooled kidney pairs.
(G) Distribution of kidney weights from P0 mice
treated for 2 days with DMSO or LDN and
harvested at 2 weeks. Error bars represent the
mean ± SE of weights and p is derived from the
Student’s t test.
(H) Relative number of glomeruli counted per kidney (glomerular index). Kidneys from seven mice per group were serially sectioned and a section
was counted every 100 mM. Error bars represent the mean ± SE and p is derived from the Student’s t test.DESIGN
We are interested in understanding early events in development
of the mammalian nephron, with the ultimate goal of recapitu-
lating nephrogenesis in vitro using defined cell populations. To
date, we have not had access to pure NPCs in the quantities
required for experimentation. Therefore, the goal of this study
was to develop an in vitro environment in which NPCs could
be propagated in an undifferentiated state, as they are in their
biological niche within the embryonic kidney. Several published
studies have characterized the signaling environment of the em-
bryonic NPC niche, the nephrogenic zone (Barak et al., 2012;
Blank et al., 2009; Brown et al., 2011a, 2013; Carroll et al.,
2005; Karner et al., 2011). For this reason, we chose a directed
approach to recapitulate the signaling environment of the neph-
rogenic zone in culture.
RESULTS
SMAD Inhibition Retains NPCs in the
CITED1-Expressing Compartment
As a starting point for the development of conditions for propa-
gation of NPCs, we made use of observations on signaling in
cap mesenchyme during the terminal stage of nephrogenesis.
We have shown that BMP7 signaling through the SMAD1/5
pathway is required for undifferentiated CITED1+/SIX2+ progen-230 Developmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Initors to transition to a CITED1/SIX2+ state in which they are
sensitized to epithelial induction by WNT/b-catenin signaling
(Figure 1A) (Brown et al., 2013). Cessation of nephrogenesis is
defined as the final round of new nephron formation in which
the last wave of NPCs undergoes mesenchyme to epithelial
transition. In the mouse, this occurs shortly after birth and is
accompanied by a reduction in Cited1+ cap mesenchyme by
P2 (Figure 1B) (Hartman et al., 2007; Rumballe et al., 2011). We
reasoned that SMAD1/5 signaling might increase during the
terminal phase of nephrogenesis, skewing the renewal versus
differentiation balance and depleting the cap mesenchyme. Im-
munostaining of mouse kidneys from embryonic day 17.5 (E17.5)
to P2 for activated SMAD1/5 (pSMAD1/5) showed that this is
indeed the case, and that an expanded domain of SMAD1/5 acti-
vation in many cap mesenchymes associates with cessation of
nephrogenesis (Figure 1C).
To understand if cap mesenchyme cells in their natural
signaling environment could be prevented from transitioning
out of the native CITED1+ progenitor cell state, we treated
newborn animals with the SMAD1/5 small molecule inhibitor
LDN-193189 (LDN) during the first 2 postnatal days. LDN is
highly specific for SMAD1/5 and has been successfully used
in vivo (Yu et al., 2008). Immunoblot of isolated nephrogenic
zone cells (NZCs) from LDN-treated animals demonstrates
greater than 95% reduction in SMAD1/5 phosphorylation
compared to controls (Figure 1D). To measure the differentiationc.
Figure 2. SMAD Inhibition with LDN-193189 Retains NPCs in the CITED1 Compartment In Vitro
(A) CITED1 immunostaining of freshly plated monolayer cultures of purified progenitors isolated at developmental time points.
(B) Quantitation of CITED1+ progenitor purity from images shown in (A). Error bars represent average values ± SD calculated from individual culture well
replicates.
(C) Stereomicroscopy and GFP expression of purified CITED1+ progenitors in aggregate culture isolated from Cited1creERT2-EGFP kidneys and treated with
CHIR (3 mM) and LDN (75 nM). Insets (stereo and H&E; 50 mM) show tubules (T) with lumens after CHIR-only treatment.status of NPCs, we used theCited1creERT2-EGFP and Six2cre-
EGFP mouse strains, which dynamically express fluorescent
protein under the control of Cited1 and Six2 promoters (Boyle
et al., 2008; Kobayashi et al., 2008). Whereas untreated animals
lost expression ofCited1 and Six2 in capmesenchyme at P2 and
P3, respectively, expression was maintained in LDN-treated
pups (Figure 1E). RT-qPCR analysis of isolated NZCs with addi-
tional marker genes that are expressed within these two com-
partments supports the conclusion that the progenitor state
had been rescued in LDN-treated capmesenchymes (Figure 1F).
We observed expression of CITED1+/SIX2+ compartment-
specific transcripts such as Cited1, Meox1, and Six2 and loss
of markers for the CITED1/SIX2+ and pretubular aggregate
(PTA) compartments, including the WNT/b-catenin response
genes Wnt4, Lef1 and Sp5. Transcription of BMP response
genes including Crossveinless-2 (Cv2) and several Inhibitors of
differentiation (Ids) was also decreased, consistent with sup-
pression of SMAD signaling by LDN (Figure 1F). Kidneys of
treated mice aged for 2 weeks after the LDN administration are
slightly larger and contain more nephrons than vehicle-treated
controls as determined by counting glomeruli in serial kidney
sections spaced 100 mm apart (Figures 1G and 1H). Although
less precise than counting all glomeruli using stereology, this in-
dex is proportional to the number of glomeruli, and nephrons, inDeveeach kidney.We conclude that inhibition of pSMAD1/5 activation
can retain cap mesenchyme cells in a Cited1+/Six2+ progenitor
cell state within their natural signaling niche and that this phar-
macological delay of CITED1+ depletion results in increased
nephron endowment.
To understand if these observations can be extrapolated to
CITED1+ cells in culture, we performed a series of experiments
on NPCs isolated from embryonic mouse kidneys. Using our
previously developed isolation protocol, CITED1+ NPCs were
harvested from embryonic kidneys between the ages of E13.5
to P1 at near 100% purity, allowing interrogation of the CITED1+
population at multiple time points (Figures 2A and 2B) (Brown
et al., 2013). However, CITED1 progenitor purity drops to 75%
by P2, likely due to the loss of CITED1+ progenitors that occurs
during cessation (Figures 1B and 2B). When aggregated on poly-
carbonate filters at the air-liquid interface and cultured in serum
free medium (aggregate cultures) in the presence of the WNT/
b-catenin agonists BIO (2 mM) or CHIR99021 (CHIR, 3 mM), these
progenitors undergo robust tubulogenesis, which depends on
endogenously produced BMP ligand (Brown et al., 2013; Osa-
fune et al., 2006). CITED1+ progenitors isolated from P0 Cited1-
creERT2-EGFP mice underwent tubulogenesis and lost GFP
expression by day 4 of CHIR treatment (Figure 2C). However,
addition of LDN blocked tubulogenesis and maintained GFPlopmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inc. 231
Figure 3. SMAD Inhibition Maintains Nephron Progenitor Potential
(A) NPEM formulation.
(B) Immunostaining of CITED1+ progenitors expanded in NPEM for 3 days in the presence or absence of LDN.
(C) Flow cytometry histogram of CITED1+ progenitors isolated fromCited1creERT2-EGFPmice propagated in complete NPEMor in the absence of the indicated
factors.
(D) Quantitation of GFP intensity (GFP (high) or GFP (low/neg)) by flow cytometry to quantify progenitor cell state in the absence of individual factors; ±SD
calculated from culture well replicates shown.
(E) pSMAD1/5 immunostaining of CITED1+ progenitors grown in NPEM with or without LDN or BMP.
(F) Cv2 expression in CITED1+ progenitors grown in NPEM in the presence or absence of LDN over 72 hr.
(G) Aggregate culture of CITED1+ progenitors isolated from Cited1creERT2-EGFP mice that were initially expanded for 3 days in monolayer in the presence or
absence of LDN.
See also Figures S1 and S2.expression. These results demonstrate that pSMAD1/5 inhibition
can retain cultured progenitors in an undifferentiated Cited1+
state in the presence of active BMP and WNT/b-catenin
signaling, suggesting that LDN treatment is key to in vitro prop-
agation of these cells.
The Developmental Regulators FGF, BMP, and WNT Are
Required for Maintenance, Expansion, and
Differentiation of CITED1+ Progenitors
To define additional factors required for NPC propagation in
monolayer, we made use of prior studies on signaling in cap
mesenchyme (Figures 1A and 3A). The addition of FGF1, 2, 9,
or 20 promotes the maintenance and proliferation of CITED1+
progenitors when cultured in monolayer on fibronectin coated
wells with keratinocyte serum free medium (KSFM) (Brown
et al., 2011a). However, these cells lost expression of cap
mesenchyme markers after 2 to 3 days and died. We chose to
use FGF9 for CITED1 maintenance and proliferation as it was
recently identified as a natural ligand for maintenance of NPCs
in vivo (Barak et al., 2012). Heparin was included because it facil-
itates the binding of FGF9 to its receptor. We have shown that
BMP activation of the JNK pathway is critical for the proliferation
of mouse NPCs (Blank et al., 2009). Although NPCs express
Bmp7, we included recombinant BMPs 4 and 7 to counteract
the dilution of endogenous BMP7 in the culture medium. These
factors function equivalently in NPC renewal (Oxburgh et al.,232 Developmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier In2005). WNT signaling is necessary for proliferation and renewal
of CITED1+ progenitors (Karner et al., 2011). Because LDN
blocks cells from transitioning to the SIX2 only state in which
they become sensitive to WNT-mediated epithelialization, we
were able to add CHIR (1.25 mM) without promoting differentia-
tion (Brown et al., 2013). The Rho kinase inhibitor Y-27632 was
included because it improves survival of dissociated stem cells
during plating and passage and supports their long-termmainte-
nance (Tsutsui et al., 2011; Watanabe et al., 2007). Insulin-like
growth factors 1 and 2 (IGF1/2) were included because they
promote cell proliferation, inhibit cell death, and are important
for kidney growth and nephron endowment in rodents (Bach
and Hale, 2015; Rogers et al., 1999). Nephron progenitor expan-
sion medium (NPEM) was formulated by supplementing APEL
medium with these factors (Figure 3A). APEL was selected as
the basal medium and Matrigel as the substrate because they
have been used in the derivation of hESC-derived NPCs
(Takasato et al., 2014). NPCs isolated from E17.5 kidneys were
plated and expanded 16-fold in NPEM and maintained robust
expression of the cap mesenchyme markers CITED1, PAX2,
andWT1 after 3 days in culture (Figure 3B). Using flow cytometry
on E17.5 CITED1+ NPCs derived from Cited1creERT2-EGFP
mice, we evaluated the requirement for each of the culture addi-
tives to maintain cells in monolayer in the undifferentiated state
by subtracting them from NPEM (Figures 3C and 3D). NPCs
grown in the absence of either FGF9 or BMP4/7 for 3 days failedc.
Figure 4. FGF, BMP, andWNT Expand Func-
tionally Competent CITED1+ NPCs
(A) Immunostaining of CITED1+ progenitors
expanded in NPEM. DAPI shown in blue. Bottom
two images show stereomicroscopy of aggregate
cultures demonstrating formation of tubule-like
structures with CHIR treatment. VEH indicates
vehicle control.
(B) Passage statistics for CITED1+ progenitors
from each developmental stage. E13.5 and E17.5
progenitors were passaged six times, whereas
P1 progenitors were cultured to passage 10 (P1
extended).
(C) Percentage CITED1+ progenitors after each
passage. Error bars represent mean ± SD from
immunofluorescence images for each passage.
(D) Number of CITED1+ progenitor doublings after
each passage for the seeding densities indicated
(k = 31,000).
(E) Expression of cap mesenchyme transcripts in
freshly isolated CITED1+ progenitors. Data repre-
sent the mean ± SD of pPCR from three biological
replicates.
(F) Wnt4 expression in CITED1+ progenitors
cultured in keratinocyte basal medium and treated
with BIO (0.5 mM) for 6 hr. Average values ± SE in
(E) and (F) shown.
See also Figures S3 and S4.to expand and displayed a shrunken morphology (Figure 3D and
Figure S1A). Cells grown in the absence of IGF1/2 maintained
CITED1 expression but cell growth was restricted compared to
complete NPEM. In the absence of the WNT agonist CHIR, cells
failed to expand but remained CITED1+ and were indistinguish-
able from cells grown in complete NPEM (Figures 3C and 3D and
Figure S1A). In the absence of the Rho kinase inhibitor Y-27632
there was a significant decrease in cell attachment to the sub-
strate, a corresponding increase in cell-cell contact, and impor-
tantly, a large proportion of NPCs transitioned out of the CITED1
compartment (Figure 3D and Figure S1A), demonstrating that
inhibition of this pathway plays an important role in maintaining
progenitor identity.
When LDN was subtracted from the medium, cells expanded
but were largely CITED1 negative (Figures 3B–3D). In the
absence of LDN, nuclear localization of pSMAD1/5 increased
dramatically, as did transcription of the SMAD response gene
Cv2 (Figures 3E and 3F). Whereas NPCs were still competentDevelopmental Cell 34, 229–to undergo tubulogenesis after subtrac-
tion of IGF1/2, Y-27632 or CHIR, the
absence of LDN rendered cells unable to
undergo differentiation after 7 days in
aggregate culture as determined by
E-cadherin (ECAD) and lotus lectin stain-
ing (LTL) (Figure 3G and Figure S1B). In
addition to losing CITED1 expression,
progenitors cultured in the absence of
LDN for 3 days lost expression of charac-
teristic marker genes including PAX2,
WT1, and SIX2, which may explain their
lack of competence (Figure 3B and Fig-
ure S2). These results demonstrate thatthe SMAD signaling branch of the BMP pathway must be sub-
dued to maintain NPC potential.
Passage and Differentiation Potential of NPCs Grown
in NPEM
In this study, the term passage is used to denote detachment,
dilution, and replating of cells for propagation. The term doubling
is used to describe a 2-fold increase in cell number within a
population. When grown in NPEM, CITED1+ progenitors isolated
from multiple developmental stages including E13.5, E17.5, and
P1 maintained expression of CITED1/SIX2 and did not express
the PTA marker LEF1 through at least six passages when de-
tached and replated (hereafter referred to as ‘‘split’’) at a con-
stant cell density determined by initial proliferation rate for
each developmental time point (Figures 4A–4C). A comprehen-
sive protocol for the isolation and culture of NPCs can be found
in the Supplemental Experimental Procedures. CITED1+ cells
proliferated vigorously in NPEM and had undergone 17–23241, July 27, 2015 ª2015 Elsevier Inc. 233
doublings by passage 6 (Figure 4B). CITED1+ progenitors from
P1 kidneys retained the ability to expand at greater than 98%
purity after 2 freeze-thaw cycles and at least ten passages
(Figures 4A–4C). CITED1+ progenitors displayed minimal slow-
ing of proliferation over many passages as determined by a
consistent time to doubling of cell number (doubling time) (Fig-
ure 4D). Interestingly, E17.5 CITED1+ progenitors seeded at a
higher cell density (50,000 versus 20,000 per cm2) and split every
3 days, displayed a substantially decreased doubling capacity
after each passage until cells no longer expanded by passage
3, demonstrating a critical need to avoid cellular overgrowth
(Figure 4D). We conclude that our attempt to recapitulate the
nephrogenic zone signaling environment for progenitor cells
successfully allows extensive propagation of undifferentiated
cells.
Cessation of nephrogenesis is associated with CITED1+
compartment depletion between P1 and P4, indicating that the
differentiation state of NPCs in this phase of nephrogenesis
might differ from cells at earlier stages (Figure 1B) (Hartman
et al., 2007). The CITED1+ compartment contains domains that
may be functionally heterogeneous and a subset that expresses
Meox1 and Dpf3 lies adjacent to the differentiating CITED1-/
SIX2+ compartment, suggesting that it is poised to differentiate
(Mugford et al., 2009). CITED1+ progenitors isolated from P1and
E17.5 kidneys show comparable expression of Cited1 and Six2,
but P1 cells express higher levels ofMeox1, suggesting that they
may have shifted to a more differentiated state (Figure 4E). Inter-
estingly, P1 progenitors also show increased Jag1, which is
normally expressed in the renal vesicle. To functionally test the
susceptibility of cells from different stages to differentiation we
isolated cells from E16.5, E17.5, P1, and P2 in KSFM medium,
which does not contain any of the factors we have identified as
essential for NPC renewal, treated them with a WNT/b-catenin
agonist, and measured Wnt4, which is expressed as NPCs
differentiate (Figure 4F and Brown et al., 2013). While treatment
elevated Wnt4 in P2 progenitors compared to E17.5 and P1, no
difference was seen between E17.5 and P1, suggesting that P1
cells purified by our isolation protocol are not yet primed for
differentiation (Figure 4F). Thus, although P1 progenitors display
a molecular marker signature consistent with a differentiated
state within the CITED1+ compartment, they do not show evi-
dence of increased sensitivity to WNT/b-catenin induction and
retain the potential to expand over one billion-fold (30 doublings)
(Figure 4B).
To confirm that in vitro propagated NPCs retain their differ-
entiation competence, we tested their capacity for epithelial in-
duction by aggregating them and culturing under organotypic
conditions at the liquid/air interface of DMEM/F12 medium con-
taining 3 mMCHIR (differentiation medium). Compared to vehicle
controls, extensive tubule-like structures were seen by stereomi-
croscopy in cells from all passages tested (Figure 4A, bottom).
Aggregates of E17.5 NPCs that had been expanded and
passaged prior to culture in differentiation conditions revealed
a marker profile characteristic of nephron differentiation (Fig-
ure 5A). This included sequential expression of LEF1 (PTA),
ECAD (epithelialization), PAX8 (comma and S-shaped body),
and LTL staining (mature proximal tubules). Progenitors isolated
from E13.5, E17.5, and P1 that were expanded through multiple
passages formed both ECAD+ and LTL+ tubule structures (Fig-234 Developmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inure 5B). In some instances, LTL+ tubules were observed that
were contiguous with ECAD+ tubules (Figure 5C). Using markers
for distal convoluted tubule (NCC) and proximal tubule (LTL)
with ECAD, we identified three distinct nephron segments in
E17.5 kidneys: LTL+/ECAD (proximal), ECAD+/NCC+ (distal),
ECAD+/NCC (undetermined, presumptive loop of Henle) (Fig-
ure 5D). Although abundant proximal and ECAD+/NCC seg-
ments could be identified in aggregates treated with CHIR, we
were initially unable to identify NCC+ distal tubules. Recent
studies of cell signaling processes that pattern the early nephron
have demonstrated that suppressing SMAD1/5 signaling pro-
motes the distal fate (Lindstro¨m et al., 2014). Hypothesizing
that differentiation fates may be skewed by the culture condi-
tions, we supplemented our differentiation medium with LDN
from days 4 to 7. ECAD+/NCC+ tubules became abundant and
could clearly be distinguished from adjacent ECAD+/NCC tu-
bules, confirming that our initial culture conditions inhibited the
distal tubule fate (Figure 5E). Thus, expanded CITED1+ progen-
itors are competent to form tubules with marker profiles of prox-
imal, distal, and presumptive intermediate tubule segments.
NPCs isolated from the E11.5 kidney display different
signaling requirements compared to those isolated at later
developmental stages, prompting us to ask if cells from this
stage can be expanded in NPEM (Brown et al., 2013). A total
of 50,000 CITED1+ cells were purified from E11.5 mesenchymes
bymagnetic depletion and cultured in NPEM onMatrigel. Similar
to later developmental stages, LDN was necessary to retain
E11.5 NPCs in an undifferentiated state while remaining compe-
tent to undergo tubulogenesis (Figure S3). Cells expanded vigor-
ously to one million after only 3 days in culture, but aggregate
assays revealed that their capacity for passaging with main-
tained differentiation capacity was severely restricted compared
to NPCs from later stages (Figure S4). The underlying reason for
the profound difference in expansion capacity between E11.5
NPCs and cells from later stages remains unclear, and we
conclude that NPEM is most useful for progenitor expansion
from E13.5 onward.
Clonally Expanded NPCs Are Competent to Form
Nephron Tubules
We demonstrated that bulk populations of pure CITED1+ pro-
genitors can be expanded in NPEMwhile retaining their potential
to undergo differentiation.We next tested amixed culture of cells
isolated from the nephrogenic zone to determine if our culture
conditions confer a selective growth advantage to NPCs. An
isolation method was used that results in a mixed population
of NZCs consisting of approximately 50% NPCs, 35% cortical
interstitial cells, and 15% other cells with trace contamination
of collecting duct cells (Blank et al., 2009; Brown et al., 2011b,
2013). Expansion of a bulk culture of these NZCs in NPEM
increased the proportion of SIX2+ cells from 50% to 85% after
two passages (Figure 6A). Clones of CITED1+ cells expanded
after 5 days in a limiting dilution assay using NZCs (Figure 6B).
Twenty independent clones were expanded for 8 days and all
tested positive for CITED1, SIX2, or PAX2, indicating preferential
outgrowth of cells of the NPC lineage (Figure 6B). We conclude
that NPCs expand preferentially in NPEM over other cell types
found within the nephrogenic zone and that NPC clones can
be expanded from a single cell using our culture conditions.c.
Figure 5. Expanded NPCs Retain Differentiation Potential
(A) Time course images of expanded CITED1+ progenitors differentiated in aggregate culture with CHIR (3 mM).
(B) Confocal microscopy of ECAD+ and LTL+ tubules from expanded CITED1+ progenitors differentiated in aggregate culture. LTL+ tubules are outlined with
dotted white lines.
(C) Contiguous LTL+/ECAD+ positive tubules differentiated in aggregate cultures with CHIR. White arrows indicate connecting junction.
(D) E17.5 kidney section (left) showing distinct proximal (cyan arrowhead), distal (red arrowhead), and an undetermined ECAD+ nephron tubule (green arrowhead)
that is not ECAD+ collecting duct (right, red arrow).
(E) Expanded E17.5 progenitors express distal tubule markers ECAD and NCC (red arrowhead) when treated in aggregate culture with CHIR (days 1–7) and LDN
(days 3–7). Green arrowhead shows adjacent ECAD+/NCC tubule.Heterogeneity of gene expression suggests that the CITED1+
compartment contains cells with varying degrees of progenitor
potential (Mugford et al., 2009). To determine if the CITED1+
compartment represents a homo- or heterogeneous progenitor
population, we performed a limiting dilution analysis. A total of
960 cells from a bulk population of E17.5 CITED1+ progenitors
were distributed across ten 96-well plates. After attachment,
the number of cells seeded per well mirrored the expected Pois-
son distribution (Figure S5A). Cells in each well were counted
and only wells containing single cells were further analyzed. After
5 days, the number of cells per clone was counted to compare
the doubling times of individual progenitors (Figure 6C). The
growth rate observed was heterogeneous with 10% of clones
doubling seven times (17 hr per average doubling), a rate higher
than that seen with our earlier low density seeding of bulk cul-
tures (31.6 hr per average doubling). Wells containing a single
colony derived from a single cell that fell within this higher prolif-Deveerating category were interrogated further to determine their
capacity for expansion.
We found that many of the larger colonies started to show
increased clustering of cells, which may subject NPCs to over-
growth and restrict growth potential or even cause spontaneous
differentiation through increased cell-cell contact. To circumvent
this and to expand our clones further, 24 high growth clones
were split and passed to two wells each, expanded to conflu-
ence and either transferred to aggregate culture for differentia-
tion or immunostained with anti-CITED1 antibody to determine
purity. Over half of the clones were greater than 90% CITED1+
and 15 grew to more than 100,000 cells (Figures 6D and S5B).
There was a correlation between CITED1 purity and total cell
expansion, with the 12 most expanded clones averaging 90%
CITED1 purity and the 12 least expanding clones averaging
only 60%purity. Several outlier clones (1, 14, and 15) had a lower
cell number after the passage and when these cells were placedlopmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inc. 235
Figure 6. NPEM Supports Clonal Expansion of Functional NPCs from a Heterogeneous CITED1+ Pool
(A) SIX2 immunostaining of isolated NZCs and CITED1+ progenitors (pass 2) expanded in NPEM.
(B) Stereomicroscopy and immunostaining of single-cell-derived colonies obtained from NZCs seeded in NPEM.
(C) Graphical representation of cell doublings in colonies seeded from a single CITED1+ progenitor.
(D) Number of cells recovered (black bars, left y axis) and percent CITED1+ (white boxes, right y axis) of single-cell seeded colonies after passage 1. Error bars
represent mean ± SD for three quantitated images.
(E) Phase contrast (left) and LTL immunostain (right) of 24 clones (from D) differentiated with CHIR (3 mM) in aggregate culture.
(F) Stereomicroscopy and confocal microscopy of an aggregate derived from a single CITED1+ progenitor after propagation in NPEM for 23 days through two
passages.
See also Figure S5.in aggregate culture, they had a reduced ability to undergo tubu-
logenesis compared to clones that were still expanding after the
passage, suggesting that they might have become compro-
mised (Figure 6E). Of the 24 clones, only one did not undergo tu-
bulogenesis (#5), and this clone was associated with the lowest236 Developmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inpercentage of CITED1+ progenitors (4%). The remaining 23
clones underwent partial to complete tubulogenesis when
subjected to differentiating conditions in aggregate culture.
One healthy clone was further expanded over 23 days including
two passages and underwent extensive tubulogenesis whenc.
Figure 7. hESC-Derived NPCs Expanded in
NPEM Medium Retain Their Capacity for
Organotypic Epithelial Differentiation
(A) CITED1 and PAX2 immunostaining of cells
differentiated for 10 days from H9 hESCs using
conditions reported previously by Takasato et al.
(2014).
(B) CITED1 and PAX2 immunostaining of cells
differentiated using the Takasato et al. (2014) pro-
cedure and expanded in NPEM.
(C) PAX2 immunostaining of ES cell-derived
progenitors expanded in NPEM with and without
LDN treatment at passage 1.
(D) Stereomicroscopy of cells differentiated using
the Takasato et al. (2014) procedure and trans-
ferred to aggregate cultures containing CHIR.
White boxes circle areas of tubulogenesis.
(E) Stereomicroscopy of cells differentiated using
the Takasato et al. (2014) procedure, expanded in
NPEM and transferred to aggregate cultures con-
taining CHIR. LTL immunostaining (boxed regions,
insets) shown in red.
(F) H&E staining of CHIR-treated aggregate cul-
tures containing cells expanded in NPEM (pass 2)
show extensive formation of tubules (T) with lu-
mens (arrows).
(G) LTL and ECAD immunostaining of CHIR-
treated aggregate cultures containing cells
expanded in NPEM (pass 2).
(H) LTL and PAX8 immunostaining of CHIR-treated
aggregate cultures containing cells expanded in
NPEM (pass 2).
See also Figures S6 and S7.transferred to aggregate (Figure 6F). Confocal microscopy of this
clonally derived aggregate showed numerous ECAD and LTL
positive tubules with lumens that can be identified by optical
sectioning. Overall, our results provide functional evidence that
the CITED1+ compartment is comprised of NPCs that display
a wide variability in progenitor potential.
Expansion of Functional NPCs Derived from hESCs
To understand if cellular growth in NPEM can be directly extrap-
olated to human cells, we repeated our analysis with NPCs
derived from hESCs using a recently published protocol (Taka-
sato et al., 2014). CITED1+/SIX2+/PAX2+/WT1+ cells generated
using this procedure lost expression of NPC markers following a
single passage (Figure 7A and Figure S6A). However, hESC-
derived NPCs could be passaged at least twice (1:8 split) with
retained molecular marker expression using our propagation
conditions (Figure 7B and Figure S6B). Subtraction of individual
components from themedium revealed a critical dependence on
FGF9, LDN, CHIR, and Y27632 for expression of CITED1, PAX2,
SIX2, and WT1 (Figure S7A). When LDN was eliminated from
the medium during the passage 2 culture, cells lost expres-
sion of PAX2 (Figure 7C). When BMP4/7 was removed, PAX2
and SIX2 expression remained robust, whereas CITED1 was
decreased and WT1 was eliminated (Figure S7A). Interestingly,
when both BMP4/7 and LDN were removed concurrently,
PAX2 expression remained, suggesting that LDN is only neces-Devesary to retain marker expression in the presence of exogenous
BMP (Figure S7B).
To evaluate the functional capacity of expanded human NPCs,
we differentiated cell aggregates from each passage. Very few
tubules formed from cells expanded during passages 0 and 1
in either medium, although the tubules that did form stained pos-
itive for LTL (Figure 7E). In contrast, cells cultured through pas-
sage 2 in NPEM underwent robust differentiation forming many
tubules containing lumens (Figures 7E and 7F). We found stain-
ing for both ECADand LTL in differentiated tubules and observed
that tubules frequently expressed both of these markers (Fig-
ure 7G). When found in tubules without ECAD, LTL staining
was confined to the luminal side of tubules, where it normally
stains L-fucose present on the surface of the microvilli that
form the brush border. This suggests that these tubules have
increased surface area, which is necessary for the resorptive
and flow sensing functions of proximal tubules in vivo. We also
observed persistent nuclear expression of PAX8, which is nor-
mally expressed in proximal and distal convoluted tubules and
loops of Henle in humans, but is decreased or absent in adult
mouse kidneys (Figure 7H and Tong et al., 2009). PAX8 staining
also shows alternating expression intensity in neighboring cells
within a tubular structure, similar to that observed in human prox-
imal tubules (Tong et al., 2009). In tubules co-expressing both
markers, LTL often overlapped with ECAD staining at cell-cell
junctions, but displayed stronger expression toward the luminallopmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier Inc. 237
side (Figure 7G). Because this pattern was only found in ECAD-
positive tubules, and ECAD expression is normally decreased
prior to terminal differentiation of the proximal tubule in mice
and rats, these structures may represent immature tubules
where microvilli have not yet formed and in which expression
of these two markers has not yet segregated. Another possibility
is that the immediate precursors to proximal and distal tubule
epithelial cells (LTL/ECAD+) have become intermixed and
given rise to a number of hybrid tubules within the organoid
culture, rather than becoming regionally restricted to a single
tubule type. Overall, we have demonstrated that NPEM expands
ES cell-derived human NPCs that are capable of robust epithe-
lialization and formation of tubules with lumens that display
expression of markers normally associated with human proximal
tubules.
DISCUSSION
We have shown that the nephrogenic zone cell signaling environ-
ment can be re-created in vitro for extensive propagation of
undifferentiated NPCs. Modulation of FGF, BMP, WNT, and
ROCK signaling pathways was necessary to maintain cells in
the CITED1+ state with epithelial differentiation potential. This
defined culture system can be used to expand embryonic mouse
NPCsandhESC-derivedNPCs for in vitro organogenesis studies.
Cell signaling requirements for mouse and human NPCs are
similar in all aspects except the requirement forBMP.Subtraction
of BMP from the culture medium of human cells resulted in only a
partial loss of the progenitormarker profile compared to the com-
plete loss observed formouse progenitors. Published differentia-
tion protocols for hESCs generate at most 50% NPCs, and
approximately half of the culture remains undefined (Lam et al.,
2014; Mae et al., 2013; Takasato et al., 2014). It therefore seems
likely that cells in the culture may be producing BMPs and other
factors that mask the effects of BMP7 withdrawal. Development
of purification procedures for human NPCs will be necessary to
directly compare the signaling requirements of hESC-derived
human NPCs with CITED1+ cap mesenchyme cells.
Limitations of the NPC Culture Procedure
The experimental procedure for isolation and propagation of
NPCs that we describe is of limited use at the earliest stages
of nephrogenesis prior to E13.5 and at terminal stages of nephro-
genesis after P1. However, we show that E13.5, E17.5, and P1
NPCs proliferate vigorously in NPEM. Two key steps of the
procedure are particularly sensitive to error. First, the initial enzy-
matic digestion of the nephrogenic zone to liberate NPCs and
other niche cells must be performed correctly. Insufficient
removal of the kidney capsule leads to a very low starting cell
number because few cells are liberated. Conversely, damaging
the kidney during the dissection will expose regions below the
nephrogenic zone and reduce the proportion of NPCs in the
cell suspension, making the magnetic depletion step less effi-
cient. Second, it is critical to control the density of NPC growth.
NPCs will begin to spontaneously differentiate when crowded,
severely limiting the passaging potential of the culture. Cultures
must be split when the most crowded zone on the culture
plate reaches 70%–80% density (Supplemental Experimental
Procedures).238 Developmental Cell 34, 229–241, July 27, 2015 ª2015 Elsevier InBMP Signaling in NPC Maintenance
FGF, BMP, and WNT each influence renewal and differentiation
of the NPC, but how the cell interprets these signals depends on
its differentiation state as well as concurrent signaling from the
surrounding niche (Brown et al., 2013; Das et al., 2013; Fetting
et al., 2014; Karner et al., 2011). BMP7 promotes NPC prolifera-
tion through aMAPK pathway, whereas pSMAD signaling transi-
tions progenitors out of the CITED1+ compartment (Blank et al.,
2009; Brown et al., 2013). Molecular mechanisms that determine
the balance of MAPK versus pSMAD activation by BMP7 in
NPCs are not understood. However, recent data suggest that
FGF signaling through PI3K/MAPK may repress pSMAD1/5
signaling in unprimed cap mesenchyme (Motamedi et al.,
2014). In our cultures, pSMAD1/5 persists in the presence of
exogenously added FGF9, suggesting that additional niche
factors present in the developing organ are required for FGF-
mediated suppression of pSMAD in the CITED1+ compartment.
A key factor in the development of our culture procedure was
the addition of the small molecule LDN, which blocks pSMAD
activity and prevents progenitors from exiting the CITED1+
compartment, while still allowing proliferation and survival sig-
nals provided by BMP stimulation.
Functional Heterogeneity within the CITED1+
Progenitor Population
Gene expression profiling of the CITED1+ capmesenchyme sug-
gests that this is not a homogenouscell population (Mugford et al.,
2009).Meox1 andDpf3 are expressed in a specific subpopulation
of CITED1+ progenitors adjacent to the more differentiated
CITED1/SIX2+ compartment and are not expressed inCITED1+
progenitors inmorecorticalcapmesenchyme.While the functions
of these transcription factors during kidney development are un-
known, their localizedexpression indicates that theCITED1+pop-
ulation may be phenotypically heterogeneous, perhaps with one
renewing sub-compartment, and one sub-compartment in the
process of exiting the CITED1+ state. Our analysis of single cells
cultured for 5 days revealed a largely binomial distribution of
cellular doubling, supporting functional heterogeneity of the
CITED1+ cap mesenchyme population. Clones derived from the
most rapidly dividing group could be expanded to several hun-
dred thousand cells that retained the potential for epithelial differ-
entiation. It seems probable that these highly proliferative clones
derive fromcells within the CITED1+ compartment with extensive
progenitor potential that might function as ‘‘super progenitors’’
from which the bulk of CITED1+ cap mesenchyme cells are
derived. Lineage analysis using a tamoxifen-inducible Cited1-
creERT2;Rosa26RLacZ strain shows that a high proportion of
cells labeled at E13.5 are retained in the cap mesenchyme at
E19.5, suggesting thepresenceof a self-renewingsub-population
(Boyle et al., 2008). An alternate possibility is that our medium
formulation provides an advantage to more differentiated cells
within the CITED1+ compartment. Single-cell transcriptome
analysis coupled with phenotyping of a large number of cap
mesenchyme cells will be required to discern the biological basis
for the heterogeneity that we see within the CITED1+ population.
The Nephrogenic Niche Regulates NPC Lifespan
Recent high-resolution studies indicate that cap mesenchyme
displays progressively decreased proliferation and thinningc.
throughout development until it is depleted (Short et al., 2014).
Based on this model and the average cell-cycle lengths
calculated for the cap mesenchyme (33 hr at E17.25), E17.5 pro-
genitors in the CITED1+ compartment are, on average, expected
to undergo two doublings prior to cessation. However, in isola-
tion, differentiation-competent E17.5 CITED1+ progenitors
doubled 17 times starting either as bulk populations or single
cells. Surprisingly, CITED1+ progenitors isolated at P1 under-
went more than 30 doublings in bulk culture. If progenitor
renewal was internally regulated by a predetermined biological
clock that counts the number of divisions, we would not expect
cells isolated from E17.5 and P1 to double more than twice.
Instead, bulk cultures of progenitors from E13.5, E17.5, and
P1 proliferate similarly, suggesting that signals limiting replica-
tive lifespan of these cells are provided by their environment.
Based on this, we speculate that the reduced speed of prolifer-
ation of P1 progenitors in vivo may underlie their depletion,
perhaps because epithelial induction by collecting duct tips is
not reduced proportionally, leading to capmesenchyme exhaus-
tion.We cannot rule out the possibility that a specific factor in the
medium resets a biological clock in NPCs that limits proliferation
potential. Further screening to compare the effect of medium
components on cells isolated from different stages of nephro-
genesis will be required to definitively answer this question.
Conclusions
This work demonstrates that our understanding of the nephro-
genic zone signaling environment is now sufficiently advanced
to allow us to emulate the niche in vitro, providing a means for
controlled expansion of NPCs. These cells can now be produced
in large quantities facilitating studies of nephron formation in a
variety of biological matrices with the ultimate goal of tissue
engraftment.
EXPERIMENTAL PROCEDURES
A detailed protocol for the isolation and propagation of NPCs can be found in
the Supplemental Experimental Procedures.
Cell Culture
CITED1+ progenitors were purified from NZCs derived from E17.5 mouse kid-
neys as previously described (Brown et al., 2011b, 2013). CITED1+ progeni-
tors were cultured in monolayer on hESC-qualified Matrigel-coated plates
(Corning). Population doublings for each cell passage were calculated in Mi-
crosoft Excel using the log base 2 formula, = LOG(N1,2)-LOG(N0,2), where 2
represents log base 2, N1 is the final cell count at the end of a passage, and
N0 is the initial seeding density at the start of a cell passage. To derive
NPCs from human ES cells, H9 ES cells (WiCell) were dissociated with TrypLE
(Life Technologies), washed in autoMACs running buffer (Miltenyi Biotec) and
plated at 10,000 cells per cm2 on Matrigel-coated 96-well plates in APEL me-
dium (Stem Cell Technologies) supplemented with 10 mM Y-27632. The
following day, the medium was changed to APEL medium containing 8 mM
CHIR99021 (Stemgent). After 48 hr, cells were exposed to APEL medium con-
taining 200 ng/ml FGF9 (R&DSystems) and 1 mg/ml heparin (Sigma-Aldrich) for
4 days. For hESC-derived NPCs grown in NPEM, the medium was then
changed to NPEM for 4 days (end of pass 0). For NPEM, recombinant proteins
were purchased from R&D Systems and chemical inhibitors were purchased
from Sigma-Aldrich, with the exception of CHIR99021. Cells grown in NPEM
were subsequently passaged 1:8 upon 100% confluence for future passages
and medium was changed every 2 days. For passaging of human and mouse
NPCs, cells were dissociated by incubation with TrypLE for 2 min at 37C,
washed, and spun twice at 3003 g in autoMACs running buffer prior to resus-Devepension in NPEM as described in Figure 3A. NPEMwas changed every 2 days.
The H9 ES cell line was used at passages 31–33 and derived as previously
described (Amit et al., 2000). Cells were differentiated in aggregate culture
with 3 mMCHIR99021 in medium as previously described (Brown et al., 2013).
Immunofluorescence and Microscopy
Tissue sections, monolayer cultures, and aggregates were immunostained as
previously described (Blank et al., 2009; Brown et al., 2013). Antibodies were
used at 1:100 dilution and include CITED1 (NeoMarkers), pSMAD1/5 (Cell
Signaling Technology), SIX2 (Proteintech); LEF1 (Cell Signaling Technology),
PAX2 (Proteintech), PAX8 (Proteintech); ECAD (BD Transduction Laboratories),
NCC (Millipore), andLTL (Vector Laboratories)wasusedat1:200.GFP+progen-
itors from Cited1creERT2-EGFP mice in monolayer or aggregate culture were
imaged with epi-fluorescent and fluorescent stereo microscopes, respectively.
qPCR
RNA purification, cDNA synthesis, and qPCR were performed as described
elsewhere (Brown et al., 2011a). Raw data are normalized to b-actin expres-
sion, and fold changes are relative to the vehicle control. Primer sequences
are listed in the Supplemental Experimental Procedures.
Flow Cytometry
CITED1+ progenitors were purified from GFP+ kidneys isolated from Cited1-
creERT2-EGFP3 ICRmice and cultured as described in the text. GFP fluores-
cence intensity and cell counts were collected on a FACSCalibur (BD) and data
were analyzed using FlowJo software.
Statistical Methods
For qPCR, kidney weights, and glomerular counts, the p values shown were
calculated using a two-tailed Student’s t test and p < 0.05 was considered
significant. Error bars for qPCR experiments represent ±SD for technical rep-
licates derived from NZCs of 20–24 pooled kidneys or ±SE for biological
replicates derived from three independent mouse litters of pooled kidneys
(Figures 4E and 4F). For flow cytometry and cell count experiments, error
bars represent average values ±SD calculated from three culture well repli-
cates. CITED1+ purity was determined from at least three independent images
by normalizing to the number of DAPI-stained nuclei in each field using ImageJ
with error bars representing the mean ± SD.
Mouse Strains and Treatments
Animal care was in accordance with the National Research Council Guide for
the Care and Use of Laboratory Animals and protocols were approved by
the Institutional Animal Care and Use Committee of Maine Medical Center.
CITED1 progenitors were derived from kidneys of Cited1creERT2-EGFP 3
ICR heterozygous mice. Cited1creERT2-EGFP and Six2cre-EGFP mouse
strains were maintained on an FVB/NJ background (Boyle et al., 2008; Ko-
bayashi et al., 2008). Pregnant mice were injected at 12 hr intervals at the times
indicated with 3 mg/kg LDN-193189 in 20 ml of DMSO/PBS.
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